探讨恶性心律失常与心衰治疗新方法

The New Methods in Treatment of Malignant Arrhythmia and Heart Failure

目的探讨分析恶性心律失常和心衰的患者接受静脉埋藏式三腔起搏器治疗的效果。方法根据2010年8月~2013年8月我院的10例恶性心律失常和心衰患者,为其行左锁骨静脉穿刺,植入静脉埋藏式三腔起搏器,对患者的临床治疗情况进行研究分析。结果患者接受三腔起搏器植入治疗后,10例患者DDD起搏和双室同步起搏成功,在对这些患者进行4个月~3年的随访中,患者有室速室颤情况时可以自动清除颤转律;10例患者的QRS波变窄,心功能改善,左室射血分数提升,在随访时没有发现并发症病例出现。结论临床中可以使用三腔心脏起搏器来改善心律失常、心衰患者的症状,让患者的生活质量得到提升,避免患者猝死。起搏器的植入对技术要求比较高,植入成功后合并症少,因此是安全可靠的治疗方式。

Objective To investigate the effect of the treatment of three-chamber pacemaker in patients with malignant arrhythmia and heart failure. Methods According to our hospital from August 2013 to August 2010, 10 cases of malignant arrhythmia and heart failure patients to study and analyze. For patients with left clavicle vein puncture,implanted vein buried three chamber pacemaker to observed the effect. Results Patients underwent chamber pacemaker implantation,10 patients with DDD pacing and dual chamber pacing were successful. Patients were followed up for 4 months to 3 years,patients with ventricular tachycardia can be automatically cleared of AF,10 cases of patients with QRS wave,cardiac function improved significantly,and left ventricular ejection fraction improved. In the course of follow-up,no complications were found. Conclusion The clinical application of three chamber cardiac pacemaker can improve the symptoms of arrhythmia and heart failure of patients,so that patients can improve the quality of life,to avoid sudden death. The implantation of the pacemaker is a relatively high technical requirements,and after the implantation of the success of the merger, it is safe and reliable.